secwatch.observer — SEC 8-K summary
======================================

Issuer:     Instil Bio, Inc. (TIL)
CIK:        0001789769
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001789769-24-000020
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Instil Bio enters collaboration for ITIL-306 preclinical manufacturing feasibility studies
--------------------------------------------------------------------------------

- Agreement with collaborator for preclinical manufacturing feasibility studies on ITIL-306 program.
- Aims to enroll patients in investigator-initiated clinical trials (IITs).
- No guidance provided on timing of data readout for ITIL-306 or IIT studies.
- Forward-looking statements subject to risks including manufacturing and enrollment uncertainties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789769/000178976924000020/0001789769-24-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789769/000178976924000020/til-20240117.htm
  HTML page:      https://secwatch.observer/filing/0001789769-24-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer